Renaissance Capital logo

Sensei Biotherapeutics Priced, Nasdaq: SNSE

Phase 2 biotech developing bacteriophage-based therapies for cancer.

Industry: Health Care

Latest Trade: $10.70 0.00 (0.0%)

First Day Return: -0.5%

Return from IPO: -43.7%

Industry: Health Care

We are a clinical-stage immunotherapy company engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. Our proprietary ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response. We are currently conducting an ongoing 30-patient Phase 1/2 clinical trial of our lead product candidate, SNS-301, in combination with the PD-1 inhibitor pembrolizumab, as a potential treatment for squamous cell carcinoma of the head and neck, or SCCHN. As of December 10, 2020, we have enrolled 11 patients in the trial, of which ten patients were evaluable for efficacy. We have observed disease control in seven of the patients evaluable for efficacy, including one patient with a partial response, or PR, and two patients who have achieved longstanding stable disease, or SD, for greater than 36 weeks following treatment. Treatment with SNS-301 has generally been well tolerated. We anticipate reporting topline data from this trial by the end of 2021. If the results of this trial are positive, subject to feedback from the U.S. Food and Drug Administration, or FDA, we intend to initiate a randomized, registration-enabling trial for SNS-301.
more less
IPO News for Sensei Biotherapeutics
more
IPO Data
IPO File Date 01/15/2021
Offer Price $19.00
Price Range $16.00 - $18.00
Offer Shares (mm) 7.0
Deal Size ($mm) $133
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 02/03/2021
Offer Price $19.00
Price Range $16.00 - $18.00
Offer Shares (mm) 7.0
Deal Size ($mm) $133
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Rockville, MD
Founded 1999
Employees 25
Website www.senseibio.com